Aptiv stock weighs Q2 EPS beat against lower guidance

Aptiv stock is trading at USD 45.02 on the NYSE on September 24, 2026, down 0.32 percent from the previous close. The company is balancing an adjusted Q2 2026 EPS beat against reduced full-year guidance, leaving execution and demand as the central investor variables.

EPS beat meets lower guidance

According to Zacks, Aptiv delivered adjusted EPS of USD 1.63 in Q2 2026, 14.8 percent above the USD 1.42 consensus and 24.4 percent above the prior-year quarter. The result shows that profitability improved even as the revenue outcome remained more restrained.

The same Q2 report put revenue at USD 3.27 billion, up 2.3 percent year over year but 1.4 percent below the USD 3.32 billion consensus. Adjusted EBITDA reached USD 613 million, while the adjusted EBITDA margin expanded to 18.7 percent from 17.1 percent in the comparable quarter, according to Zacks.

Revenue guidance sets the test

Aptiv guided for Q3 2026 revenue of USD 3.12 billion to USD 3.22 billion and adjusted EPS of USD 1.25 to USD 1.35. For fiscal 2026, the company expects revenue of USD 12.6 billion to USD 12.8 billion, below its previous USD 12.8 billion to USD 13.2 billion range, while adjusted EPS guidance moved to USD 5.60 to USD 5.80 from USD 5.70 to USD 6.10.

The guidance reset matters because the Q2 earnings beat came from margin expansion rather than rapid sales growth. Aptiv's portfolio spans automotive, aerospace and defense, energy, enterprise, industrial and robotics, medical, and telecom applications, according to the company's website.

Stock stays close to yearly low

Aptiv's September 24 intraday price of USD 45.02 stood USD 2.03 above its 52-week low of USD 42.99 and USD 43.91 below its 52-week high of USD 88.93. The gap to the high is 49.4 percent, while the market capitalization was USD 9,528,023,536 at the same snapshot.

For investors, the key tension is measurable: adjusted EPS exceeded consensus by USD 0.21, but revenue missed by USD 50 million and the full-year revenue range moved lower. Aptiv stock therefore reflects a margin recovery story that still depends on renewed top-line expansion.